Kazunori Aoki

12PUBLICATIONS
75CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 16, 2026
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.

|Jan 27, 2026
Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Hiroki Ishihara, Yu-Yu Liu, Riu Yamashita

|Jul 08, 2025
EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer.

Kosuke Arai, Yukari Nishito, Hideaki Mizuno

|Mar 25, 2024
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments.

Hironori Fukuda, Kosuke Arai, Hideaki Mizuno

|Aug 22, 2023
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.

Shuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka

|Jun 28, 2023
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.

Kazunori Aoki, Yukari Nishito, Noriko Motoi

Pageof 2

Frequent Collaborators

4 joint publications

Shigehisa Kitano

4 joint publications

Atsushi Ochiai

4 joint publications

Nobuyoshi Hiraoka

3 joint publications

Hironori Fukuda